Cognitive Dysfunction: all 3,932 studies

Page 15 of 40. Open to participants first (1,115), then studies with results posted, then the rest; newest registration first within each.

• Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive ImpairmentTerminatedNCT02317783Phase 2Results posted
• Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot StudyCompletedNCT02312934Phase 2Results posted
• Influence of Beta Amyloid Imaging on Care of Patients Cognitive Complaints.CompletedNCT02309723Not applicableResults posted
• Cognitive Training and Practice Effects in Mild Cognitive ImpairmentCompletedNCT02301546Not applicableResults posted
• AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer DiseaseTerminatedNCT02284906Phase 3Results posted
• Trajectory of Recovery in the ElderlyCompletedNCT02275026Not applicableResults posted
• Galantamine and Memantine Combination for Cognitive Impairments in SchizophreniaTerminatedNCT02234752Phase 2Results posted
• Extension Study of Intrathecal Enzyme Replacement for Cognitive Decline in MPS ITerminatedNCT02232477Not applicableResults posted
• Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or ThoracotomyCompletedNCT02213900Phase 4Results posted
• Methylphenidate Treatment of Attention Deficits in EpilepsyCompletedNCT02178995Phase 4Results posted
• Improving Medication Adherence in Older African Americans With DiabetesCompletedNCT02174562Not applicableResults posted
• Remote Preconditioning Over Time To Empower Cerebral TissueTerminatedNCT02169739Not applicableResults posted
• Promoting Adaptive Neuroplasticity in Mild Cognitive ImpairmentCompletedNCT02155946Not applicableResults posted
• Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple SclerosisCompletedNCT02133664Phase 1/2Results posted
• Transcranial Direct Current Stimulation (tDCS) As A Treatment For Cigarette Craving and Cognitive Deficits in SchizophrenicCompletedNCT02128919Not applicableResults posted
• Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in WomenCompletedNCT02122198Not applicableResults posted
• Curcumin as a Novel Treatment to Improve Cognitive Dysfunction in SchizophreniaCompletedNCT02104752Phase 1/2Results posted
• Nattokinase Atherothrombotic Prevention StudyCompletedNCT02080520Not applicableResults posted
• PET Imaging in MCI Following ADT for PCaCompletedNCT02061345Results posted
• Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive ImpairmentCompletedNCT02055118Phase 2/3Results posted
• Reversal of General Anesthesia With MethylphenidateCompletedNCT02051452Phase 1/2Results posted
• Rehabilitation of Attention in Patients With MCI and Brain Subcortical Vascular Changes Using the APT-IICompletedNCT02033850Not applicableResults posted
• Markers of Alzheimers Disease and Cognitive Outcomes After Perioperative CareCompletedNCT01993836Phase 4Results posted
• CAndesartan vs LIsinopril Effects on the BRainCompletedNCT01984164Phase 2Results posted
• Memory Training Versus Yogic Meditation Training in Older Adults With Mild Cognitive ImpairmentCompletedNCT01983930Not applicableResults posted
• Enhancing Spatial Navigation Using Non-Invasive Brain StimulationCompletedNCT01958437Not applicableResults posted
• Complementary Neurosteroid Intervention in Gulf War Illnesses (GWVI)CompletedNCT01956279Phase 2Results posted
• Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)TerminatedNCT01953601Phase 3Results posted
• Olfactory Deficits and Donepezil Treatment in Cognitively Impaired ElderlyCompletedNCT01951118Phase 4Results posted
• Study of Repetitive Transcranial Magnetic Stimulation in the Treatment of Cognitive Impairment in SchizophreniaCompletedNCT01940939Not applicableResults posted
• Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its OnsetTerminatedNCT01931566Phase 3Results posted
• Brain Aging and Treatment Response in Geriatric DepressionCompletedNCT01902004Phase 4Results posted
• Characterizing and Predicting Drug Effects on CognitionCompletedNCT01889602Phase 4Results posted
• Memantine Plus Es-citalopram in Elderly Depressed Patients With Cognitive ImpairmentCompletedNCT01876823Phase 2/3Results posted
• The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With SchizophreniaTerminatedNCT01874756Phase 2Results posted
• Olfactory Deficits in MCI as Predictor of Improved Cognition on DonepezilCompletedNCT01845636Phase 4Results posted
• Preoperative Cognitive Screening of Elderly Surgical PatientsCompletedNCT01826825Results posted
• Body Temperature in Persons With Tetraplegia When Exposed to ColdCompletedNCT01822535Phase 4Results posted
• Beta-Amyloid Imaging With [18F]NAV4694 PET in Predicting Progression to AD in Subjects MCITerminatedNCT01812213Phase 2Results posted
• Nicotine Treatment of Cognitive Decline in Down SyndromeCompletedNCT01778946Phase 1/2Results posted
• The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)CompletedNCT01767909Phase 2/3Results posted
• The Difference in Cerebral Oxygenation Between Propofol and SevofluraneCompletedNCT01757561Results posted
• Validation of the Freund Clock Drawing Test to Screen for Cognitive Dysfunction in Cancer PatientsCompletedNCT01749995Results posted
• The MENDS2 Study, Maximizing the Efficacy of Sedation and Reducing Neurological Dysfunction and Mortality in Septic Patients With Acute Respiratory FailureCompletedNCT01739933Phase 3Results posted
• Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog)CompletedNCT01738191Phase 2Results posted
• Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive DeclineCompletedNCT01703702Phase 4Results posted
• Optimization of Desflurane in Elderly PatientsCompletedNCT01700907Phase 1/2Results posted
• Indiana University Dementia Screening TrialCompletedNCT01699503Not applicableResults posted
• Effectiveness of an Electronic Training Program for Orienting and Interpreting [18F]Flutemetamol Positron Emission Tomography (PET) ImagesCompletedNCT01672827Phase 3Results posted
• Rivastigmine Patch in Veterans With Cognitive Impairment Following TBICompletedNCT01670526Phase 3Results posted
• A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive DeclineCompletedNCT01669915Not applicableResults posted
• A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)CompletedNCT01662882Phase 2/3Results posted
• Combination Treatment Study for Memory Impairment and DepressionCompletedNCT01658228Phase 4Results posted
• Consumption of Potatoes, Avocados and Chickpeas and Cognitive Function in Older AdultsCompletedNCT01620567Not applicableResults posted
• Study of Exelon Transdermal Patch in Amnestic Mild Cognitive Impairment PatientsTerminatedNCT01602198Not applicableResults posted
• Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)CompletedNCT01595646Phase 2Results posted
• Efficacy and Safety of Actovegin in Post-stroke Cognitive Impairment (PSCI)CompletedNCT01582854Phase 3Results posted
• Conversations as a Means to Delay the Onset of Alzheimer's DiseaseCompletedNCT01571427Early Phase 1Results posted
• Efficacy of Lu AA21004 on Cognitive Dysfunction in Major Depressive DisorderCompletedNCT01564862Phase 2Results posted
• Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's DiseaseTerminatedNCT01561430Phase 1/2Results posted
• Cardiac Surgery Neuroprotection Study in EldersCompletedNCT01561378Phase 2Results posted
• Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET ScansCompletedNCT01550549Not applicableResults posted
• A Study of the Safety and Tolerability of AZD5213 Effect on Sleep for Patients With Alzheimer's/Cognitive ImpairmentCompletedNCT01548287Phase 2Results posted
• Effects of Atomoxetine in Mild Cognitive ImpairmentCompletedNCT01522404Phase 2Results posted
• Mild Cognitive Impairment in Parkinson's DiseaseCompletedNCT01519271Phase 4Results posted
• Clinical Evaluation of Florbetapir F 18 (18F-AV-45)CompletedNCT01518374Phase 2Results posted
• Mild Cognitive Impairment and Obstructive Sleep ApneaCompletedNCT01482351Not applicableResults posted
• Study of Donepezil in Female Breast Cancer Survivors With Cognitive DysfunctionCompletedNCT01466270Phase 2Results posted
• Minocycline in Patients With Alzheimer's DiseaseCompletedNCT01463384Phase 2Results posted
• Efficacy and Safety Study of Shenwu CapsuleCompletedNCT01451749Phase 3Results posted
• Risk Evaluation and Education for Alzheimer's Disease (REVEAL) IVCompletedNCT01434667Not applicableResults posted
• A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive ImpairmentCompletedNCT01429623Phase 2Results posted
• Efficacy Study of Vortioxetine on Cognitive Dysfunction in Adult Patients With Major Depressive DisorderCompletedNCT01422213Phase 3Results posted
• Cognitive Remediation and Work Therapy in the Initial Phase of Substance Abuse TreatmentCompletedNCT01410110Phase 2Results posted
• Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive DeclineCompletedNCT01400425Phase 3Results posted
• 18-Month Study of Memory Effects of CurcuminCompletedNCT01383161Phase 2Results posted
• Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and KivexaCompletedNCT01367236Phase 4Results posted
• Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's DiseaseCompletedNCT01354691Phase 2Results posted
• Antiglucocorticoid Therapy for Cognitive Impairment in Late-life Anxiety DisordersCompletedNCT01333098Phase 1/2Results posted
• Study of Intravenous Immunoglobulin in Amnestic Mild Cognitive ImpairmentCompletedNCT01300728Phase 2Results posted
• Preventing Cognitive Decline in African Americans With Mild Cognitive ImpairmentCompletedNCT01299766Phase 3Results posted
• Non-cancer Pain and Cognitive Impairment: A Disabling RelationshipTerminatedNCT01264965Phase 4Results posted
• Effects of Strengthening Exercise on the Brain for Early Dementia and Normative Older AdultsCompletedNCT01264614Not applicableResults posted
• A Pilot Clinical Trial of Exendin-4 in Alzheimer's DiseaseTerminatedNCT01255163Phase 2Results posted
• The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) StudyCompletedNCT01211522Phase 3Results posted
• Cerebral Oximetry and Neurological Outcomes in Aortic Arch Surgery PatientsCompletedNCT01149148Phase 3Results posted
• GAME Veterans With PTSD Using Computer-Based Cognitive TrainingCompletedNCT01087775Not applicableResults posted
• Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue SyndromeCompletedNCT01071044Phase 4Results posted
• Treximet for Prevention of Post Traumatic Headache Associated With Cognitive DysfunctionTerminatedNCT01053507Phase 4Results posted
• Cognitive Function in Elderly Marathon RunnersStatus unknownNCT01045031Results posted
• Levetiracetam and Memory Function in Amnestic Mild Cognitive Impairment (MCI)CompletedNCT01044758Phase 2Results posted
• Cognitive Rehabilitation of Operations Iraqi Freedom and Enduring Freedom (OIF/OEF) Veterans With Cognitive DisorderCompletedNCT01040858Not applicableResults posted
• Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's DiseaseCompletedNCT01028053Phase 3Results posted
• Oxytocin or Galantamine Versus Placebo for the Treatment of Negative Symptoms and Cognitive Impairments in SchizophreniaCompletedNCT01012167Phase 2Results posted
• Gabapentin Treatment of Cannabis DependenceCompletedNCT00974376Phase 2Results posted
• Lidocaine For Neuroprotection During Cardiac SurgeryCompletedNCT00938964Not applicableResults posted
• Guanfacine Treatment for Prefrontal Cognitive Dysfunction in Elderly SubjectsCompletedNCT00935493Not applicableResults posted
• A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive ImpairmentCompletedNCT00934375Phase 4Results posted
• Cerebral Oximetry and Neurocognitive Functions in Cardiosurgical PatientsCompletedNCT00917124Not applicableResults posted
• MemoryXL Effects on Mild Cognitive Impairment PatientsTerminatedNCT00903695Phase 2Results posted

← Cognitive Dysfunction overview